Saturday 17 October 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
46.91
0.84
−1.76%
Follow PACS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 8 | 7 | — |
+8 more TTM periods Free account |
| 27.92% | 27.11% | 22.96% | 21.90% | ||
| 4.82% | 4.37% | 3.54% | 3.33% | ||
ROIC |
21.42% | 21.93% | 17.52% | 23.15% | |
Return on Tangible Assets |
20.63% | 18.71% | 15.09% | 15.90% | |
Average Days of Receivables |
47.60 | 49.27 | 48.45 | 49.34 | |
Free Cash Flow per Share |
2.89 | 2.43 | 1.92 | 2.51 | |
Free Cash Flow |
456.53 | 381.55 | 299.57 | 393.31 | |
Capital Expenditures |
(116.72) | (108.77) | (104.65) | (78.89) | |
| Other line items | |||||
Cash ROIC |
29.92% | 24.10% | 19.99% | 26.47% | |
Accounts Receivable Turnover |
7.85 | 7.37 | 7.46 | 7.79 | |
Accounts Payable Turnover |
27.82 | 24.05 | 24.55 | 24.47 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
12.68 | 14.46 | 15.56 | 17.02 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.30) | (0.31) | (0.33) | (0.35) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.97% | 7.89% | 7.85% | 7.61% | |
Share Based Compensation of Revenue |
1.34% | 1.15% | 1.02% | 0.99% | |
Interest Coverage |
13.88 | 13.68 | 10.92 | 9.86 | |
Operating CF/Net income |
2.13 | 2.01 | 2.11 | 2.79 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
(1.64) | (1.69) | (1.78) | (1.40) | |
Revenue per Share |
35.11 | 34.58 | 33.86 | 32.82 | |
Operating CF per Share |
3.63 | 3.12 | 2.59 | 3.02 | |
Capex per Share |
(0.74) | (0.69) | (0.67) | (0.50) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates